Literature DB >> 23114673

Elucidating the mechanism of posterior reversible encephalopathy syndrome: a case of transient blindness after central venous catheterization.

Neal M Rao1, Radoslav Raychev, Doojin Kim, David S Liebeskind.   

Abstract

INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a condition characterized by reversible symptoms including headache, visual disturbances, focal neurological deficits, altered mentation, and seizures. It has been associated with circumstances that may affect the cerebrovascular system, such as hypertension, eclampsia, and immunosuppression with calcineurin inhibitors. The underlying etiology of PRES has remained unclear; however, cerebrovascular autoregulatory dysfunction, hyperperfusion, and endothelial activation have been implicated. CASE REPORT: We describe a case of a young patient with lung transplant, who presented with headache, acute binocular blindness, and seizure immediately after infusion of saline through a peripherally inserted central catheter line, which inadvertently terminated cephalad in the left internal jugular vein, near the jugular foramen. Subsequent brain magnetic resonance imaging revealed vasogenic edematous lesions in a pattern consistent with PRES--a diagnosis supported by his constellation of symptoms, history of lung transplantation on tacrolimus immunosuppression, and relative hypertension.
CONCLUSIONS: This is the first reported case describing the development of PRES after the insertion of a peripherally inserted central catheter line. The development of PRES in a typical high-risk patient immediately after cerebral venous outflow obstruction implicates the role of the cerebral venous system and provides potential insight into the mechanism of this disorder that remains of unclear pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114673      PMCID: PMC3487112          DOI: 10.1097/NRL.0b013e31826a9954

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  14 in total

1.  Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging.

Authors:  S T Engelter; J R Petrella; M J Alberts; J M Provenzale
Journal:  AJR Am J Roentgenol       Date:  1999-12       Impact factor: 3.959

2.  The development of tacrolimus in renal transplantation.

Authors:  R Shapiro
Journal:  Transplant Proc       Date:  2001 Nov-Dec       Impact factor: 1.066

3.  PRES (posterior reversible encephalopathy syndrome), a rare complication of tacrolimus therapy.

Authors:  P Hodnett; J Coyle; K O'Regan; M M Maher; N Fanning
Journal:  Emerg Radiol       Date:  2008-12-19

Review 4.  Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.

Authors:  A J Olyaei; A M de Mattos; W M Bennett
Journal:  Curr Opin Crit Care       Date:  2001-12       Impact factor: 3.687

5.  Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging.

Authors:  Lauren M Brubaker; J Keith Smith; Yueh Z Lee; Weili Lin; Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

6.  Serial investigation of perfusion disturbances and vasogenic oedema in hypertensive encephalopathy by diffusion and perfusion weighted imaging.

Authors:  P C Sundgren; B Edvardsson; S Holtås
Journal:  Neuroradiology       Date:  2002-02-16       Impact factor: 2.804

7.  Role of veins and cerebral venous pressure in disruption of the blood-brain barrier.

Authors:  W G Mayhan; D D Heistad
Journal:  Circ Res       Date:  1986-08       Impact factor: 17.367

Review 8.  Neurotoxicity of immunosuppressive drugs.

Authors:  E F Wijdicks
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

Review 9.  Kidney disease after heart and lung transplantation.

Authors:  R D Bloom; A M Doyle
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

Review 10.  Cardiovascular toxicities of immunosuppressive agents.

Authors:  Leslie W Miller
Journal:  Am J Transplant       Date:  2002-10       Impact factor: 8.086

View more
  3 in total

1.  Features of infratentorial-predominant posterior reversible encephalopathy syndrome.

Authors:  Ryan T Fitzgerald; Rohan S Samant; Manoj Kumar; Rudy Van Hemert; Edgardo J Angtuaco
Journal:  Acta Neurol Belg       Date:  2015-01-21       Impact factor: 2.396

2.  Non-invasive bedside assessment of central venous pressure: scanning into the future.

Authors:  Jacques Rizkallah; Megan Jack; Mahwash Saeed; Leigh Anne Shafer; Minh Vo; James Tam
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

3.  Retinal changes in solid organ and bone marrow transplantation patients.

Authors:  Fernando Korn Malerbi; Sergio Henrique Teixeira; Luis Gustavo Gondo Hirai; Nilson Hideo Matsudo; Adriano Biondi Monteiro Carneiro
Journal:  Einstein (Sao Paulo)       Date:  2017 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.